MARKET

RDNT

RDNT

RadNet
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.84
-1.03
-6.49%
After Hours: 14.84 0 0.00% 16:00 09/21 EDT
OPEN
15.43
PREV CLOSE
15.87
HIGH
15.43
LOW
14.64
VOLUME
197.53K
TURNOVER
--
52 WEEK HIGH
23.45
52 WEEK LOW
5.81
MARKET CAP
765.37M
P/E (TTM)
-55.8735
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
RadNet Expands its Revolving Credit Facility to $195 million
LOS ANGELES, Aug. 31, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 332 owned and/or operated outpatient imaging centers, today announced the amendment of its senior
GlobeNewswire · 08/31 11:00
RadNet expands its revolving credit facility to $195M
RadNet (RDNT) has amended its senior secured first lien credit agreement to increase the amount of the revolving commitments thereunder by $57.5M, bringing the total now to $195M revolving credit
Seekingalpha · 08/31 10:07
Raymond James Maintains Outperform on RadNet, Raises Price Target to $22
Raymond James maintains RadNet (NASDAQ:RDNT) with a Outperform and raises the price target from $18.5 to $22.
Benzinga · 08/11 12:22
RadNet (RDNT) Reports Q2 Loss, Tops Revenue Estimates
RadNet (RDNT) delivered earnings and revenue surprises of 61.90% and 3.18%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/10 11:30
RadNet Q2 EPS $(0.16) Down From $0.10 YoY, Sales $190.57M Miss $190.57M Estimate
RadNet (NASDAQ:RDNT) reported quarterly losses of $(0.16) per share. This is a 260 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $190.57
Benzinga · 08/10 10:08
RadNet Reports Second Quarter Financial Results
* As a result of taking immediate expense and cash savings measures to react to the impact of COVID-19 on patient volume, RadNet finished the quarter with a cash balance exceeding $84 million and was undrawn on its $137.5 million revolving line of credit * Ra
GlobeNewswire · 08/10 10:00
RadNet and Hologic Announce Collaboration to Advance the Development of Artificial Intelligence Tools in Breast Health
Collaboration will include data sharing, R&D; and an upgrade of RadNet’s fleet of Hologic mammography systems to state-of-the-art imaging technologyLOS ANGELES and MARLBOROUGH, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- RadNet, Inc. (Nasdaq: RDNT), a national le
GlobeNewswire · 08/06 10:00
Earnings Preview: RadNet (RDNT) Q2 Earnings Expected to Decline
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 08/03 16:31
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RDNT stock price target is 21.67 with a high estimate of 23.00 and a low estimate of 20.00.
EPS
Institutional Holdings
Institutions: 208
Institutional Holdings: 40.66M
% Owned: 78.84%
Shares Outstanding: 51.57M
TypeInstitutionsShares
Increased
46
1.27M
New
50
385.20K
Decreased
49
2.68M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-2.06%
Healthcare Providers & Services
-2.69%
Key Executives
Chairman/Chief Executive Officer/President/Director
Howard Berger
Chief Financial Officer/Executive Vice President
Mark Stolper
Corporate Executive
Stephen Forthuber
Corporate Executive
Norman Hames
Executive Vice President - Finance
Mital Patel
Executive Vice President/General Counsel
David Katz
Executive Vice President
Michael Murdock
Senior Vice President/Director of Human Resources/Director
Ruth Wilson
Vice President/Secretary/Director
John Crues
Lead Director/Independent Director
David Swartz
Independent Director
Marvin Cadwell
Independent Director
Lawrence Levitt
Independent Director
Michael Sherman
  • Dividends
  • Splits
  • Insider Activity
No Data

Analyst Price Target

The average RDNT stock price target is 21.67 with a high estimate of 23.00 and a low estimate of 20.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About RDNT
RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. As of December 31, 2016, the Company had in operation 257 MRI systems, 157 CT systems, 47 PET or combination PET/CT systems, 48 nuclear medicine systems, 479 X-ray systems, 279 mammography systems, 551 ultrasound systems and 104 fluoroscopy systems.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of RadNet Inc. stock information, including NASDAQ:RDNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RDNT stock methods without spending real money on the virtual paper trading platform.